Inhibition of the KCNQ1 gene in pancreatic beta cells can increase insulin secretion and insulin granules exocytosis, whereas overexpression decreases insulin exocytosis and secretion, thereby enhancing T2DM susceptibility (6, 7). The gene discussed is INS; the disease is type 2 diabetes mellitus.